TechJournal South
Header

Posts Tagged ‘Harbert Venture Partners’

Privaris closes on $3.17M debt offering for biometric ID

Monday, April 18th, 2011

PrivarisCHARLOTTESVILLE, VA - Privaris Inc., a Charlottesville-VA-based company that makes biometric ID products, has closed on $3.17 million  million in debt, according to a regulatory filing.

Privaris raised $2.67 million in debt in June, $2 million in November 2009, and a $15.7 million A round in 2005.

The company’s institutional investors include Harbert Venture Partners, Noro-Moseley Partners, River Cities Capital Funds, RedShift Ventures, and SpaceVest Capital. It was funded by private individuals prior to its first round in 2005.

In the filing with the US Securities and Exchange Commission disclosing the financing, principals cited include: Brian Carney and Wayne Hunter, Richmond-based Harbert Venture Partners and Edward McCarthy of Raleigh-based River Cities Capital Funds.

The core Privaris product is a patented, wireless, keychain device that uses fingerprint-based biometrics to authenticate its user prior to releasing the information needed to perform a transaction.

The products work with existing physical and IT security infrastructure to authenticate the identity of an individual prior to that individual being granted access to facilities, IT resources, services and transactions.

The fingerprint data is stored and processed only on the device and is never released so as to protect an individual’s personal privacy.

TechJournal South is a TechMedia company. TechMedia presents the annual conferences:

SoutheastVentureConference: www.seventure.org

Internet Summit: www.internetsummit.com

Digital East: www.digitaleast.com

Digital Summit: www.digitalsummit.com

Privaris raises $2.9M for biometric keychain security devices

Wednesday, February 23rd, 2011

PrivarisRALEIGH, NC – Privaris Inc., a company that sells which makes biometric ID products, has raised $2.96 million in debt, according to a regulatory filing. The company raised $2.67 million in debt in June, $2 million in November 2009, and a $15.7 million A round in 2005.

The company’s institutional investors including Harbert Venture Partners, Noro-Moseley Partners, River Cities Capital Funds, RedShift Ventures, and SpaceVest Capital. It was funded by private individuals prior to its first round in 2005.

In the filing with the US Securities and Exchange Commission disclosing the financing, principals cited include: Brian Carney and Wayne Hunter, Richmond-based Harbert Venture Partners and Edward McCarthy of Raleigh-based River Cities Capital Funds.

The core Privaris product is a patented, wireless, keychain device that uses fingerprint-based biometrics to authenticate its user prior to releasing the information needed to perform a transaction.

The products work with existing physical and IT security infrastructure to authenticate the identity of an individual prior to that individual being granted access to facilities, IT resources, services and transactions.

The fingerprint data is stored and processed only on the device and is never released so as to protect an individual’s personal privacy.

TechJournal South is a TechMedia company. TechMedia presents the annual conferences:

SoutheastVentureConference: www.seventure.org

Internet Summit: www.internetsummit.com

Digital East: www.digitaleast.com

Digital Summit: www.digitalsummit.com

Florida Opportunity Fund investing $3M in 5AM Ventures

Tuesday, February 9th, 2010

The Florida Opportunity Fund has made a commitment of $3 million to 5AM Ventures II, a bioscience venture capital fund that recently completed an investment with a life sciences startup company in South Florida.

With the commitment to 5AM Ventures, the Florida Opportunity Fund has announced five investments from the States $29.5 million fund.Fund managers have been on an aggressive schedule since 2009 to make commitments that will attract more venture dollars to the State.

An investor syndicate led by 5AM Ventures recently announced an $8 million investment in Envoy Therapeutics Inc.Based in Jupiter, FL.

Envoy attracting large pharma partners

Envoy is developing new therapeutics for psychiatric and neurological diseases such as schizophrenia, Parkinsons disease, Alzheimers disease and epilepsy.

The company already has attracted significant interest from large pharmaceutical companies, including a partnership with Merck & Co., Inc. and an equity investment from Roche Venture Fund andTakeda Research Investment.

5AM is building relationships with companies in Gainesville, Tampa Bay, Cocoa Beach and Fort Lauderdale, with a focus on product development, drug discovery and medical technology.

The venture fund projects its Florida investments could total in excess of $15 million during the next 5 years.

Todays announcement follows a Florida Opportunity Fund commitment of $4 million announced January 13, 2010, toHarbert Venture Partners, a regional venture capital firm that has opened its first Florida office in Gainesville to focus on opportunities in information technology and healthcare.